Brain tumor endpoints

Executive Summary

Clinical trial endpoints for primary brain tumors will be the topic of the next public workshop in FDA's series of oncology endpoint meetings, to be held Jan. 20. "Issues identified in the workshop will be further discussed before the Oncologic Drugs Advisory Committee and thereafter will be detailed in FDA guidance documents," the agency said Nov. 22. The agency has previously hosted public meetings on lung, colorectal and prostate cancers (1"The Pink Sheet" June 28, 2004, p. 40). The workshop will be held at the Marriott in North Bethesda, Md., beginning at 8 a.m....